BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 21198721)

  • 1. Prevalent aetiologies of non-therapeutic warfarin anticoagulation in a network of pharmacist-managed anticoagulation clinics.
    Cryder B; Felczak M; Janociak J; Dela Pena L; Allen S; Gutierrez P
    J Clin Pharm Ther; 2011 Feb; 36(1):64-70. PubMed ID: 21198721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.
    Wong YM; Quek YN; Tay JC; Chadachan V; Lee HK
    J Clin Pharm Ther; 2011 Oct; 36(5):585-91. PubMed ID: 21070296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting warfarin-related knowledge and INR control of patients attending physician- and pharmacist-managed anticoagulation clinics.
    Hasan SS; Shamala R; Syed IA; Basariah N; Chong DW; Mei TK; Chin OH
    J Pharm Pract; 2011 Oct; 24(5):485-93. PubMed ID: 21844213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of pharmacist-managed oral anticoagulation therapy in older veterans.
    Poon IO; Lal L; Brown EN; Braun UK
    J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health care expenditures and therapeutic outcomes of a pharmacist-managed anticoagulation service versus usual medical care.
    Hall D; Buchanan J; Helms B; Eberts M; Mark S; Manolis C; Peele P; Docimo A
    Pharmacotherapy; 2011 Jul; 31(7):686-94. PubMed ID: 21923456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two different models of anticoagulation management services with usual medical care.
    Rudd KM; Dier JG
    Pharmacotherapy; 2010 Apr; 30(4):330-8. PubMed ID: 20334453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy.
    Garwood CL; Dumo P; Baringhaus SN; Laban KM
    Pharmacotherapy; 2008 Jan; 28(1):20-6. PubMed ID: 18154470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery.
    Meijer K; Kim YK; Carter D; Schulman S
    Thromb Haemost; 2011 Feb; 105(2):232-8. PubMed ID: 21173999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosing options for decreasing the time to achieve therapeutic anticoagulation when reinitiating warfarin: a case series.
    Schultz KT; Bungard TJ
    Pharmacotherapy; 2011 Aug; 31(8):793-805. PubMed ID: 21923606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of warfarin therapy managed by pharmacists via hospital anticoagulation clinic versus online anticoagulation clinic.
    Cao H; Wu J; Zhang J
    Int J Clin Pharm; 2018 Oct; 40(5):1072-1077. PubMed ID: 29956134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated international normalized ratio from vitamin K supplement discontinuation.
    Miesner AR; Sullivan TS
    Ann Pharmacother; 2011 Jan; 45(1):e2. PubMed ID: 21205949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a warfarin adherence aid on anticoagulation control in an inner-city anticoagulation clinic population.
    Nochowitz B; Shapiro NL; Nutescu EA; Cavallari LH
    Ann Pharmacother; 2009 Jul; 43(7):1165-72. PubMed ID: 19549747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of heart failure exacerbations on anticoagulation: a prospective, observational, pilot cohort study.
    Ripley TL; Harrison D; Germany RE; Adamson PB
    Clin Ther; 2010 Mar; 32(3):506-14. PubMed ID: 20399987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Warfarin-antibiotic interactions in older adults of an outpatient anticoagulation clinic.
    Ghaswalla PK; Harpe SE; Tassone D; Slattum PW
    Am J Geriatr Pharmacother; 2012 Dec; 10(6):352-60. PubMed ID: 23089199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department.
    Anthony CJ; Karim S; Ackroyd-Stolarz S; Fry A; Murphy NG; Christie R; Zed PJ
    Ann Pharmacother; 2011 Jul; 45(7-8):881-7. PubMed ID: 21750309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of physician- and pharmacist-managed warfarin sodium treatment in open heart surgery patients.
    Tschol N; Lai DK; Tilley JA; Wong H; Brown GR
    Can J Cardiol; 2003 Nov; 19(12):1413-7. PubMed ID: 14631476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of pharmacist-based compared to doctor-based anticoagulation management in Qatar.
    Elewa H; Jalali F; Khudair N; Hassaballah N; Abdelsamad O; Mohammed S
    J Eval Clin Pract; 2016 Jun; 22(3):433-8. PubMed ID: 26766552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of hemorrhage among patients with warfarin-associated coagulopathy.
    Garcia DA; Regan S; Crowther M; Hylek EM
    J Am Coll Cardiol; 2006 Feb; 47(4):804-8. PubMed ID: 16487849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.